A Bioinspired Design of Self-Adjuvanted C3d-Fusion SARS-CoV-2 mRNA Vaccines
Invention type: Technology
/
Case number: #23326
Researchers
Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Chemicals & Materials: Nanotechnology & Nanomaterials / Drug Discovery and Research Tools: Cell Interrogation / Therapeutics: Small Molecules, Vaccines
Impact Areas: Healthy Living
-
compositions and methods for adjuvanted vaccines
United States of America | Published application -
compositions and methods for adjuvanted vaccines
Patent Cooperation Treaty | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.